CDC25C — Cell Division Cycle 25C

CDC25C — Cell Division Cycle 25C

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CDC25C — Cell Division Cycle 25C</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>CDC25C</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>CDC25C — Cell Division Cycle 25C</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=CDC25C" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

The CDC25C gene encodes a member of the CDC25 family of dual-specificity phosphatases that play critical roles in regulating cell cycle progression[@cdc25c_structure_2021]. CDC25C specifically controls the G2/M checkpoint by activating CDK1 (also known as CDC2) through the removal of inhibitory phosphorylations on Tyr15 and Thr14[@cdc25c_cdk1_2019]. This activation is essential for mitotic entry and proper cell division.

Beyond its well-characterized role in cell cycle regulation, emerging research has revealed connections between CDC25C dysfunction and neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS)[@cdc25c_neuro_2017]. The re-entry of post-mitotic neurons into the cell cycle is a well-documented phenomenon in neurodegeneration, and CDC25C appears to play a key role in this process.

CDC25C — Cell Division Cycle 25C

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CDC25C — Cell Division Cycle 25C</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>CDC25C</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>CDC25C — Cell Division Cycle 25C</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=CDC25C" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

The CDC25C gene encodes a member of the CDC25 family of dual-specificity phosphatases that play critical roles in regulating cell cycle progression[@cdc25c_structure_2021]. CDC25C specifically controls the G2/M checkpoint by activating CDK1 (also known as CDC2) through the removal of inhibitory phosphorylations on Tyr15 and Thr14[@cdc25c_cdk1_2019]. This activation is essential for mitotic entry and proper cell division.

Beyond its well-characterized role in cell cycle regulation, emerging research has revealed connections between CDC25C dysfunction and neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS)[@cdc25c_neuro_2017]. The re-entry of post-mitotic neurons into the cell cycle is a well-documented phenomenon in neurodegeneration, and CDC25C appears to play a key role in this process.

Gene and Protein Structure

Gene Location and Organization

The CDC25C gene is located on chromosome 5q31.2 and encodes a protein of 473 amino acids with a molecular weight of ~53 kDa[@cdc25c_structure_2021]. The gene contains 14 exons and is conserved across eukaryotes, reflecting its fundamental role in cell division.

Protein Structure and Domains

CDC25C contains several functional domains:

The three-dimensional structure of CDC25C has been solved, revealing the catalytic core and regulatory regions that interact with CDK1/cyclin B complexes[@cdc25c_structure_2021].

Function in Cell Cycle Regulation

G2/M Checkpoint Control

CDC25C is the key phosphatase that drives cells from G2 into mitosis[@cdc25c_cdk1_2019]. The process involves:

• Activation of CDK1: CDC25C removes inhibitory phosphates from CDK1 at Tyr15 (by WEE1 kinase) and Thr14 (by MYT1 kinase)
• Positive feedback loop: CDK1/cyclin B phosphorylates and activates CDC25C, creating a positive feedback loop that ensures irreversible mitotic entry
• Checkpoint recovery: Following DNA repair, CDC25C activity is restored to allow cell cycle progression

Regulation by DNA Damage

DNA damage triggers cell cycle arrest through CDC25C inhibition[@cdc25c_dna_damage_2020]:

• ATM/ATR activation: DNA damage sensors activate CHK1 and CHK2 kinases
• CHK1/CHK2 phosphorylation: These kinases phosphorylate CDC25C at Ser216, creating a binding site for 14-3-3 proteins
• Sequestration: 14-3-3 binding traps CDC25C in the cytoplasm, preventing CDK1 activation
• Cell cycle arrest: This mechanism ensures DNA repair before mitotic entry

Subcellular Localization

The localization of CDC25C is tightly regulated throughout the cell cycle[@cdc25c_localization_2016]:

• Interphase: CDC25C is primarily cytoplasmic
• G2/M transition: CDC25C translocates to the nucleus
• Mitosis: Nuclear accumulation reaches maximum levels
• Checkpoint activation: DNA damage causes rapid export to cytoplasm

Role in Neurodegeneration

Alzheimer's Disease

CDC25C has been implicated in Alzheimer's disease pathogenesis through several mechanisms[@cdc25c_ad_pathology_2016]:

• Neuronal cell cycle re-entry: Post-mitotic neurons in AD brain show evidence of cell cycle re-entry, with increased CDC25C expression
• Tau pathology: CDC25C-mediated CDK1 activation can lead to tau hyperphosphorylation, contributing to neurofibrillary tangle formation[@cdc25c_tau_2014]
• Amyloid-beta effects: Aβ exposure triggers cell cycle activation in neurons, involving CDC25C upregulation
• Synaptic dysfunction: Cell cycle activation leads to synaptic loss and dendritic degeneration

Parkinson's Disease

In Parkinson's disease, CDC25C dysregulation has been observed in dopaminergic neurons[@cdc25c_pd_2019]:

• Increased expression: PD brain tissue shows elevated CDC25C levels in substantia nigra neurons
• Alpha-synuclein connection: α-synuclein aggregation can trigger cell cycle activation
• Mitochondrial dysfunction: Cell cycle dysregulation compounds mitochondrial impairment in PD
• Therapeutic implications: CDC25C inhibitors may protect vulnerable neurons

Amyotrophic Lateral Sclerosis

CDC25C has been implicated in ALS pathogenesis[@cdc25c_als_2018]:

• Motor neuron vulnerability: Cell cycle activation has been documented in ALS motor neurons
• Protein aggregation: TDP-43 pathology is associated with cell cycle dysregulation
• Oxidative stress: DNA damage in ALS triggers checkpoint activation

Mechanisms of Neuronal Dysfunction

Cell Cycle Re-entry Hypothesis

The cell cycle re-entry hypothesis proposes that neurons attempt to re-enter the cell cycle in response to various stresses[@cdc25c_neuro_2017]:

Apoptosis versus Cell Cycle

CDC25C can promote either cell cycle progression or apoptosis depending on context[@cdc25c_apoptosis_2013]:

• Mild stress: Cell cycle arrest and repair
• Severe stress: Apoptotic cell death
• Chronic activation: Progressive neuronal dysfunction

DNA Damage Response

Neurons are particularly vulnerable to DNA damage accumulation[@cdc25c_dna_repair_2012]:

• Chronic DNA damage: Accumulates with aging
• Checkpoint activation: DNA damage activates CHK1/CHK2, leading to CDC25C inhibition
• Prolonged arrest: Can lead to neuronal dysfunction and death

Molecular Mechanisms in Alzheimer's Disease

CDC25C-Mediated CDK1 Activation and Tau Pathology

The connection between CDC25C and Alzheimer's disease centers on its ability to activate CDK1, which in turn phosphorylates tau protein at multiple sites[@cdc25c_tau_2014]. This pathway represents a critical link between cell cycle dysregulation and the hallmark tau pathology of AD:

Direct Tau Phosphorylation

CDK1, when activated by CDC25C, phosphorylates tau at several AD-relevant sites:

• Ser202/Thr205: Site targeted by multiple kinases in AD
• Ser396: Major phosphorylation site in neurofibrillary tangles
• Thr231: Important for tau microtubule binding disruption

• Axonal transport deficits
• Synaptic dysfunction
• Formation of paired helical filaments
• Neurofibrillary tangle accumulation

CDK1-Tau Kinase Cascade

CDC25C-mediated CDK1 activation triggers a cascade of kinases:

Therapeutic Implications

Understanding the CDC25C-CDK1-tau axis suggests potential therapeutic strategies:

• CDC25C inhibitors: Block premature CDK1 activation
• CDK1 inhibitors: Prevent tau phosphorylation
• Combination therapy: Target multiple nodes in the pathway

Cell Cycle Re-Entry in AD Progression

The re-entry of post-mitotic neurons into the cell cycle is now recognized as a hallmark of AD pathology[@cdc25c_neuro_2017]. CDC25C plays a central role in this process:

Stages of Cell Cycle Re-Entry

• Partial activation of cell cycle proteins
• CDC25C expression begins to increase
• Neurons attempt cell cycle progression

• Significant CDC25C upregulation
• CDK1/cyclin B complex formation
• Limited tau phosphorylation

• High CDC25C levels
• Extensive CDK1 activation
• Widespread tau pathology
• Neuronal loss

Molecular Triggers

Multiple triggers can initiate cell cycle re-entry:

• Amyloid-beta oligomers: Bind to receptors and activate signaling cascades
• Oxidative stress: DNA damage activates checkpoint pathways
• Tau pathology: May itself trigger cell cycle activation
• Mitochondrial dysfunction: Energy stress activates stress pathways
• Synaptic activity changes: Altered neuronal activity affects cell cycle regulators

Molecular Mechanisms in Parkinson's Disease

Alpha-Synuclein and Cell Cycle Dysregulation

In Parkinson's disease, CDC25C dysregulation connects to the hallmark alpha-synuclein pathology[@cdc25c_pd_2019]:

Direct Effects

Alpha-synuclein aggregation affects cell cycle regulation through:

• Nucleolar dysfunction: α-syn localizes to nucleolus, disrupting rRNA transcription
• p53 activation: Aggregates trigger stress responses
• CDC25C upregulation: Cell cycle activation in affected neurons

Signaling Pathways

Multiple pathways connect α-syn to CDC25C:

Dopaminergic Neuron Vulnerability

Substantia nigra dopaminergic neurons show particular sensitivity to cell cycle dysregulation:

Selective Vulnerability

• High metabolic demand → increased oxidative stress
• Intrinsic bioenergetics → mitochondrial vulnerability
• Pacemaker activity → chronic calcium influx
• Axonal length → increased transport burden

CDC25C in PD Pathogenesis

The role of CDC25C in PD includes:

• Increased expression in surviving neurons
• Attempted cell cycle progression leading to apoptosis
• Interaction with PD genes (LRRK2, GBA, SNCA)
• Potential therapeutic target

CDC25C in Amyotrophic Lateral Sclerosis and Related Disorders

Motor Neuron Vulnerability

CDC25C dysregulation has been observed in ALS and related motor neuron diseases[@cdc25c_als_2018]:

TDP-43 Connection

• TDP-43 pathology includes cell cycle dysregulation
• CDC25C expression increased in ALS motor neurons
• Cell cycle activation may contribute to TDP-43 aggregation

Mechanisms

Broader Neurodegenerative Implications

Cell cycle dysregulation, including CDC25C alterations, appears in:

• Huntington's disease
• Frontotemporal dementia
• Multiple sclerosis
• Traumatic brain injury

Therapeutic Implications

CDC25 Inhibitors in Cancer

CDC25C is overexpressed in many cancers, making it a therapeutic target[@cdc25c_cancer_2018]:

• Small molecule inhibitors: Multiple CDC25 inhibitors have been developed
• Clinical trials: Several compounds have entered clinical testing
• Resistance mechanisms: Tumor cells can develop resistance through various pathways

Neurodegeneration Therapy

Targeting CDC25C in neurodegeneration presents both opportunities and challenges[@cdc25c_inhibitors_2020]:

• Inhibition rationale: Blocking cell cycle re-entry could protect neurons
• Therapeutic window: Must balance cell cycle inhibition with necessary functions
• Delivery challenges: CNS penetration required
• Combination approaches: May need combined targeting of multiple cell cycle proteins

Drug Development Strategies

Recent efforts have focused on developing CDC25-targeted compounds:

• Phosphatase inhibitors: Small molecules targeting the catalytic domain
• Protein-protein interaction disruptors: Blocking CDC25C-CDK1 interaction
• Allosteric modulators: Compounds binding to regulatory regions

Clinical Relevance

Biomarker Potential

CDC25C expression and phosphorylation status may serve as[@cdc25c_biomarker_2022]:

• Disease progression markers: Correlate with neurodegeneration severity
• Therapeutic response indicators: Monitor treatment efficacy
• Risk stratification: Identify patients at higher risk

Diagnostic Applications

• Immunohistochemistry: Detect CDC25C in postmortem brain tissue
• ELISA assays: Measure soluble CDC25C in cerebrospinal fluid
• Flow cytometry: Assess cell cycle status in patient-derived cells

Neural Stem Cells and Neurogenesis

Role in Neural Progenitor Cells

CDC25C plays a critical role in neural stem cell biology[@cdc25c_stem_cells_2021]:

• Proliferation control: Regulates cell cycle progression in neural progenitor cells
• Differentiation timing: Coordinates cell cycle exit with neuronal differentiation
• Neurogenesis regulation: Essential for proper forebrain development

Implications for Brain Repair

Understanding CDC25C function in neural stem cells has implications for:

• Regenerative therapies: Modulating CDC25C to enhance neurogenesis
• Aging research: Age-related changes in neural stem cell cycle control
• Disease modeling: iPSC-derived neural models for drug discovery

Regulation of CDC25C Activity

Phosphorylation Networks

CDC25C activity is controlled by multiple phosphorylation events[@cdc25c_phosphorylation_2017]:

Activation Phosphorylation

• Ser198: Autophosphorylation enhancing activity
• Ser205: Positive regulatory site
• Ser214: Contributes to nuclear accumulation

Inactivation Phosphorylation

• Ser216: 14-3-3 binding site, critical for checkpoint
• Ser249: Negative regulatory site
• Thr148: MYT1 kinase target

Protein-Protein Interactions

CDC25C interacts with multiple regulatory proteins:

Subcellular Trafficking

CDC25C localization is tightly regulated[@cdc25c_localization_2016]:

Nuclear-Cytoplasmic Shuttling

• Nuclear import: Importin-mediated, NLS-dependent
• Nuclear export: CRM1-dependent, regulated by phosphorylation
• Cytoplasmic retention: 14-3-3 binding maintains cytoplasmic pool

Spatial Regulation During Mitosis

Research Models and Future Directions

Stem Cell Models

iPSC-derived neurons from AD/PD patients provide relevant models:

• Patient-specific cell cycle behavior
• Disease-relevant phenotype modeling
• Drug screening platforms
• Mechanism studies

Animal Models

Transgenic and knockout models illuminate:

• Cell cycle re-entry mechanisms
• Tau pathology development
• Neuronal survival factors
• Therapeutic intervention effects

Future Research Directions

References